Wall Street analysts predict that Tabula Rasa HealthCare Inc (NASDAQ:TRHC) will announce $0.07 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Tabula Rasa HealthCare’s earnings, with estimates ranging from ($0.02) to $0.16. Tabula Rasa HealthCare posted earnings of $0.10 per share during the same quarter last year, which would suggest a negative year over year growth rate of 30%. The company is expected to announce its next earnings report on Tuesday, May 14th.
According to Zacks, analysts expect that Tabula Rasa HealthCare will report full year earnings of $0.86 per share for the current fiscal year, with EPS estimates ranging from $0.62 to $1.41. For the next financial year, analysts anticipate that the business will post earnings of $1.29 per share, with EPS estimates ranging from $0.75 to $2.09. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that that provide coverage for Tabula Rasa HealthCare.
Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings data on Thursday, February 28th. The company reported $0.05 EPS for the quarter, missing the Zacks’ consensus estimate of $0.12 by ($0.07). The business had revenue of $57.31 million during the quarter, compared to analyst estimates of $55.70 million. Tabula Rasa HealthCare had a negative net margin of 23.14% and a positive return on equity of 7.76%.
NASDAQ TRHC traded down $2.46 during trading hours on Monday, reaching $53.96. The company’s stock had a trading volume of 326,685 shares, compared to its average volume of 412,814. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of 158.71 and a beta of 1.65. Tabula Rasa HealthCare has a fifty-two week low of $35.50 and a fifty-two week high of $91.16. The company has a current ratio of 0.84, a quick ratio of 0.79 and a debt-to-equity ratio of 0.32.
In related news, CFO Brian W. Adams sold 3,035 shares of Tabula Rasa HealthCare stock in a transaction dated Thursday, January 3rd. The stock was sold at an average price of $57.45, for a total value of $174,360.75. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President Orsula V. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction dated Thursday, January 17th. The stock was sold at an average price of $64.65, for a total value of $517,200.00. The disclosure for this sale can be found here. Insiders sold a total of 54,057 shares of company stock worth $3,175,138 in the last three months. 14.00% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently modified their holdings of TRHC. Eqis Capital Management Inc. raised its position in Tabula Rasa HealthCare by 3.2% in the 4th quarter. Eqis Capital Management Inc. now owns 6,156 shares of the company’s stock valued at $392,000 after purchasing an additional 193 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in Tabula Rasa HealthCare by 4.2% in the 4th quarter. State of Alaska Department of Revenue now owns 5,676 shares of the company’s stock worth $361,000 after purchasing an additional 231 shares in the last quarter. Comerica Bank lifted its stake in Tabula Rasa HealthCare by 1.4% in the 4th quarter. Comerica Bank now owns 16,519 shares of the company’s stock worth $934,000 after purchasing an additional 235 shares in the last quarter. D.A. Davidson & CO. lifted its stake in Tabula Rasa HealthCare by 3.8% in the 4th quarter. D.A. Davidson & CO. now owns 7,335 shares of the company’s stock worth $468,000 after purchasing an additional 270 shares in the last quarter. Finally, Legal & General Group Plc lifted its stake in Tabula Rasa HealthCare by 0.9% in the 4th quarter. Legal & General Group Plc now owns 36,450 shares of the company’s stock worth $2,305,000 after purchasing an additional 318 shares in the last quarter. 78.00% of the stock is currently owned by hedge funds and other institutional investors.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.